Compounded tirzepatide (tirzepatide): the 2026 buyer's guide
Compounded tirzepatide is the same active molecule as Zepbound and Mounjaro, prepared by a 503A pharmacy under prescription rather than manufactured under FDA new-drug approval. Of all the GLP-1s in our chart, this is the one with the most active regulatory exposure: Eli Lilly has filed coordinated lawsuits against compounded tirzepatide pharmacies through 2025-2026. Programs that still offer it are operating under explicit enforcement risk. Below: how it works, what it costs and the supply continuity risk to weigh against the savings.
Compare Compounded tirzepatide prices →- Compounded tirzepatide is a weekly injection, prepared by 503A pharmacies under prescription, not FDA-approved as a drug product.
- In the SURMOUNT-1 (parent molecule, Zepbound) trial, mean weight loss was 20.9% over 72 weeks, with 56.7% of patients losing 15% or more of body weight.
- It carries the GLP-1 class boxed warning for thyroid C-cell tumor risk, and is not for people with a personal or family history of medullary thyroid carcinoma or MEN2.
- Cash, insurance and compounded prices differ widely. See the cost breakdown below, and the all-in program costs on the chart.
What Compounded tirzepatide costs in 2026
There is no one price. What you pay depends on which path you take:
Telehealth programs add a membership fee on top of the medication cost (typically $40-$200/mo). For all-in monthly costs by program, see the chart, the full GLP-1 cost guide, or calculate your exact all-in cost by drug, coverage and state.
Who it's for
Same prescribing audience as Zepbound in practice (BMI ≥30, or BMI ≥27 with comorbidity), though the prescription is for a compounded product rather than the FDA-approved branded version.
What the trials show
Compounded tirzepatide's registration trial was SURMOUNT-1 (parent molecule, Zepbound) (NEJM, 2022). At 72 weeks at the maximum dose, mean weight loss was 20.9% (17.8 percentage points greater than placebo). 91% of patients lost at least 5% of body weight; 56.7% lost at least 15%. Real-world results vary; trial patients are typically more adherent and more closely managed than typical telehealth patients.
Dose schedule
Dose levels: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg. Standard practice is to titrate up monthly, holding at any tolerated dose. Maximum dose is Typically titrated to 10-15mg weekly to mirror Zepbound; many patients reach goal weight at sub-maximum doses and stay there.
Common side effects
The most commonly reported side effects in the registration trial:
- Same profile as branded tirzepatide; nausea, diarrhea, constipation, vomiting most common
- Real-world reports of injection-site reactions vary by 503A pharmacy
- Higher reported rate of supply disruption mid-treatment vs compounded semaglutide
Boxed warning: Same class warning as branded tirzepatide. Compounded preparations are not subject to FDA's full new-drug-approval safety review.
How Compounded tirzepatide differs from related drugs
Same molecule as Zepbound at the same doses. Cheapest path to tirzepatide. Insurance does not cover. Active enforcement risk; supply continuity is the single biggest practical concern. Patients sensitive to mid-treatment supply disruption should weigh branded Zepbound or compounded semaglutide as alternatives.
Programs that prescribe Compounded tirzepatide
These programs in our chart prescribe Compounded tirzepatide (with insurance coverage where applicable, or as a cash-pay option). Ranked by overall score.
Some visit links earn us a commission.
Compounded tirzepatide vs other GLP-1s
Learn more about Compounded tirzepatide
References
- SURMOUNT-1 (parent molecule, Zepbound) registration trial. New England Journal of Medicine, 2022.
- FDA: compounding and the FDA, questions and answers.
- Tirzepatide prescribing information, branded versions (DailyMed).
Trial figures are mean results at the maximum dose in the cited registration trial. Real-world outcomes vary with adherence and clinical management.
Editorial disclosure
GLP Chart is an editorial comparison site. We do not dispense, prescribe or fulfill medications. Talk to a licensed clinician about whether Compounded tirzepatide is appropriate for you. Pricing reflects publicly verified rates as of June 22; verify with the manufacturer or your prescriber before committing.
